Months after Health Canada deemed graphene-enhanced face masks as a "potential health hazard", ZEN Graphene Solutions announced receiving an approval from Health Canada for its ZENGuard™ disposable face mask with biocidal coating and is rated at an ASTM Level 3. An extensive review process took place, after which Health Canada validated ZENGuard™-enhanced surgical masks as 'safe for use by Canadians'.
In addition, ZEN Graphene Solutions also announced that it has delivered and generated revenue from its first shipment of ZENGuard antimicrobial coating to Trebor Rx. This first commercial shipment was enabled by a successful ramp up from bench scale production to pilot scale capacity, which currently exceeds the amount needed to coat 30 million masks per month. The company also reports that the engineering work on its industrial plant with an estimated capacity to coat the equivalent of 800 million masks per month is in the procurement stage. ZEN expects the build out and commissioning of the plant to be completed during the fourth quarter.
Greg Fenton, ZEN CEO commented: “The achievement of our first commercial sale of ZENGuardTM to our partner Trebor marks the beginning of what we expect to be a very compelling growth story for the prevention pillar of our health care portfolio in the months and years ahead.”
Just a few days ago, ZEN Graphene Solutions finalized a definitive commercial agreement with Trebor Rx.